Skip to content
2000
Volume 1, Issue 1
  • ISSN: 2210-299X
  • E-ISSN: 2210-3007

Abstract

Background

Pyrimidines have been shown to possess numerous biological activities, such as antimicrobial, anticancer, anticonvulsant, antiviral, and anti-inflammatory.

Objective

Encouraged by these data, the synthesis of 2-((1-benzo[]imidazol-2-yl)methylthio)-4- amino-6-phenylpyrimidine-5-carbonitrile (3a-g) was performed.

Methods

4-amino-2-mercapto-6-phenylpyrimidine-5-carbonitrile was dissolved in an aqueous sodium hydroxide solution, and to this clear solution, 2-chloromethyl-1-benzimidazole in methanol was added, and the reaction mixture was stirred under reflux to get the desired product. The structures of the newly synthesized compounds were confirmed by their physical, chemical, and spectral data. The synthesized derivatives were screened for their antibacterial activity against Gram-positive bacteria, and , and Gram-negative bacteria, and , by using ciprofloxacin as a reference standard. While, their antifungal activity was evaluated against and using fluconazole as a reference drug. The docking study was performed to check the interactions of target compounds (3a-g) with homo sapiens DHFR (PDB: 1S3V), bacterial () DHFR (PDB: 2W9T), and DHPS (PDB: 1AD4) protein. The dock score and binding interactions were recorded.

Results

The antimicrobial activity study indicated compounds with chloro (3b), fluoro and bromo (3g) substituents to show good antibacterial as well as antifungal activity. The docking study revealed that the same compounds, , 3b, 3f, and 3g, showed good dock score and comparable interactions compared to the reference ligand (trimethoprim/sulfadiazine), which confirmed their selectivity.

Conclusion

It can be presumed that the synthesized compounds have the capability for further promotion as novel antimicrobial agents.

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cis/10.2174/2210299X01666230515090431
2023-08-01
2025-09-04
Loading full text...

Full text loading...

/deliver/fulltext/cis/1/1/CIS-1-E150523216888.html?itemId=/content/journals/cis/10.2174/2210299X01666230515090431&mimeType=html&fmt=ahah

References

  1. MacGowanA. MacnaughtonE. Antibiotic resistance.Medicine (Abingdon)2017451062262810.1016/j.mpmed.2017.07.006
    [Google Scholar]
  2. VermaV. JoshiC.P. AgarwalA. SoniS. KatariaU. A Review on pharmacological aspects of pyrimidine derivatives.J. Drug Deliv. Ther.202010535836110.22270/jddt.v10i5.4295
    [Google Scholar]
  3. NatarajanR. Anthoni SamyH.N. SivaperumanA. SubramaniA. SubramaniA. Structure-activity relationships of pyrimidine derivatives and their biological activity - a review.Med. Chem.2022191103035579151
    [Google Scholar]
  4. SongM. ZhaoW. ZhuY. LiuW. DengX. HuangY. Design, synthesis, and evaluation of anticonvulsant activities of new triazolopyrimidine derivatives.Front Chem.20221092528110.3389/fchem.2022.92528135815216
    [Google Scholar]
  5. SeverinaH. SkupaO.O. VoloshchukN.I. SuleimanM.M. GeorgiyantsV.A. Synthesis and anticonvulsant activity of 6-methyl-2-((2-oxo-2-arylethyl)thio)pyrimidin-4(3 H)-one derivatives and products of their cyclization.Pharmacia201966314114610.3897/pharmacia.66.e38137
    [Google Scholar]
  6. ProvenzaniR. San-Martin-GalindoP. HassanG. LegeharA. KallioA. XhaardH. FallareroA. Yli-KauhaluomaJ. Multisubstituted pyrimidines effectively inhibit bacterial growth and biofilm formation of Staphylococcus aureus. Sci. Rep.2021111793110.1038/s41598‑021‑86852‑533846401
    [Google Scholar]
  7. MahapatraA. PrasadT. SharmaT. Pyrimidine: A review on anticancer activity with key emphasis on SAR.Future J Pharma Sci20217112310.1186/s43094‑021‑00274‑8
    [Google Scholar]
  8. TylińskaB. WiatrakB. CzyżnikowskaŻ. Cieśla-NiechwiadowiczA. GębarowskaE. Janicka-KłosA. Novel pyrimidine derivatives as potential anticancer agents: Synthesis, biological evaluation and molecular docking study.Int. J. Mol. Sci.2021228382510.3390/ijms2208382533917090
    [Google Scholar]
  9. JadhavP.A. BaravkarA. PRANALI A JADHAV ATUL BARAVKAR Recent advances in antimicrobial activity of pyrimidines: A review.Asian J. Pharm. Clin. Res.202115241010.22159/ajpcr.2022.v15i2.43686
    [Google Scholar]
  10. TolbaM.S. El-DeanA.M.K. AhmedM. HassanienR. SayedM. ZakiR.M. MohamedS.K. ZawamS.A. Abdel-RaheemS.A.A. Synthesis, reactions, and applications of pyrimidine derivatives.Curr Chem Lett202211112113810.5267/j.ccl.2021.8.002
    [Google Scholar]
  11. RaimondiM. RandazzoO. La FrancaM. BaroneG. VignoniE. RossiD. CollinaS. DHFR inhibitors: Reading the past for discovering novel anticancer agents.Molecules2019246114010.3390/molecules2406114030909399
    [Google Scholar]
  12. Abd El-AleamR.H. GeorgeR.F. HassanG.S. Abdel-RahmanH.M. Synthesis of 1,2,4-triazolo[1,5-a]pyrimidine derivatives: Antimicrobial activity, DNA Gyrase inhibition and molecular docking.Bioorg. Chem.20209410341110.1016/j.bioorg.2019.10341131711767
    [Google Scholar]
  13. PanneerselvamT. MandhadiJ.R. Microwave assisted synthesis and antimicrobial evaluation of novel substituted thiosemicarbazide derivatives of pyrimidine.J. Heterocycl. Chem.20205783082308810.1002/jhet.4013
    [Google Scholar]
  14. Al-JubooriS.B. MahmoodA.A.R. Synthesis, antimicrobial evaluation, density functional theory, and docking studies of some new 2-mercapto pyrimidine schiff bases.Asian J. Pharm. Clin. Res.201912249650210.22159/ajpcr.2019.v12i2.30858
    [Google Scholar]
  15. KhatriT.T. ShahV.H. Effective microwave synthesis of bioactive thieno[2,3-d]pyrtmidines.J. Chil. Chem. Soc.20176213354335810.4067/S0717‑97072017000100010
    [Google Scholar]
  16. ShehabW.S. AssyM.G. MoustafaH.Y. AbdellattifM.H. RahmanH.M.A. Pyrimidines as block units in heterocycles: novel synthesis of pyrimidines and condensed pyrimidine derivatives.J. Indian Chem. Soc.20191624512461
    [Google Scholar]
  17. Fernández-VillaD. AguilarM.R. RojoL. Folic acid antagonists: Antimicrobial and immunomodulating mechanisms and applications.Int. J. Mol. Sci.20192020499610.3390/ijms2020499631601031
    [Google Scholar]
  18. ShamshadH. BakriR. MirzaA.Z. Dihydrofolate reductase, thymidylate synthase, and serine hydroxy methyltransferase: Successful targets against some infectious diseases.Mol. Biol. Rep.20224976659669110.1007/s11033‑022‑07266‑835253073
    [Google Scholar]
  19. HeJ. QiaoW. AnQ. YangT. LuoY. Dihydrofolate reductase inhibitors for use as antimicrobial agents.Eur. J. Med. Chem.202019511226810.1016/j.ejmech.2020.11226832298876
    [Google Scholar]
  20. HitchingsG.H. BurchallJ.J. Inhibition of folate biosynthesis and function as a basis for chemotherapy.Adv. Enzymol. Relat. Areas Mol. Biol.20062741746810.1002/9780470122723.ch94387360
    [Google Scholar]
  21. PatilDR SalunkheSM DeshmukhMB AnbhulePV One step synthesis of 6-amino-5-cyano-4-phenyl-2-Mercapto pyrimidine using phosphorous pentoxide.Catal J201038386
    [Google Scholar]
  22. PetkarK. ParekhP. MehtaP. KumariA. BaroA. Synthesis and evaluation of 2-chloromethyl-1H-benzimidazole derivatives as antifungal agents.Int. J. Pharm. Pharm. Sci.201352115119
    [Google Scholar]
  23. KokareC. Pharmaceutical Microbiology Principles and Applications.9th edNirali Publication2013
    [Google Scholar]
  24. VilarS. CozzaG. MoroS. Medicinal chemistry and the molecular operating environment (MOE): Application of QSAR and molecular docking to drug discovery.Curr. Top. Med. Chem.20088181555157210.2174/15680260878678662419075767
    [Google Scholar]
  25. DarA.M. MirS. Molecular docking: Approaches, types, applications and basic challenges.J. Anal. Bioanal. Tech.2017821310.4172/2155‑9872.1000356
    [Google Scholar]
  26. HawserS. LociuroS. IslamK. Dihydrofolate reductase inhibitors as antibacterial agents.Biochem. Pharmacol.200671794194810.1016/j.bcp.2005.10.05216359642
    [Google Scholar]
  27. CapassoC. SupuranC.T. Sulfa and trimethoprim-like drugs – antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors.J. Enzyme Inhib. Med. Chem.201429337938710.3109/14756366.2013.78742223627736
    [Google Scholar]
  28. Available From: www.rcsb.org
/content/journals/cis/10.2174/2210299X01666230515090431
Loading
/content/journals/cis/10.2174/2210299X01666230515090431
Loading

Data & Media loading...


  • Article Type:
    Research Article
Keyword(s): Antibacterial; Antimicrobial; DHFR; DHPS; Docking; Pyrimidine
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test